Federal authorities have given Princeton University permission to use Bexsero, a vaccine against meningitis not yet approved for general use in the United States, The New York Times reported. Seven people at Princeton have come down with a strain of meningitis in the last year, and that strain is not covered by the vaccination approved for use in the United States. Princeton is considering the use of Bexsero, and has also started a number of other efforts, such as discouraging students at parties from sharing the same cups.
- Essay on requests for 'additional materials' in academic job searches
- Debating role of student learning in federal ratings plan
- Essay on changing ideas of time, space and learning in higher ed
- Moody’s: Sequester May Hurt Research Universities’ Credit Ratings
- Studies question effectiveness of state performance-based funding
- Pearson to report student outcomes, review investments as part of efficacy initiative
- How is a new president supposed to clean house?
- Union conference marks growth of adjunct organizing strategy
Search for Jobs